Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Co-transporter-2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06249932
What this trial is testing

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Who this might be right for
Heart Failure with Reduced Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital 95
Large-scale testing (Phase 3)Study completedNCT06405178
What this trial is testing

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovary
Beni-Suef University 200
Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Not applicableStudy completedNCT06902493
What this trial is testing

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

Who this might be right for
SepsisSeptic ShockAcute Kidney Injury
University of Jazan 664
Very early researchUnknownNCT04780438
What this trial is testing

Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.

Who this might be right for
Atrial Fibrillation RecurrentPulmonary Venous IsolationCatheter Ablation+1 more
G.Gennimatas General Hospital 350
Very early researchUnknownNCT04806633
What this trial is testing

Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention

Who this might be right for
Left Cardiac CatheterizationPercutaneous Coronary InterventionAcute Kidney Injury+1 more
G.Gennimatas General Hospital 1,722
Post-approval studies (Phase 4)Study completedNCT02653482
What this trial is testing

Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure

Who this might be right for
Chronic Heart Failure With Reduced Systolic Function
Saint Luke's Health System 263
Large-scale testing (Phase 3)Looking for participantsNCT05345327
What this trial is testing

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
The George Institute 994
Post-approval studies (Phase 4)Study completedNCT06094920
What this trial is testing

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Who this might be right for
Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus, Type 2Diabetes Mellitus+10 more
University Medical Center Groningen 12
Not applicableStudy completedNCT05993897
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

Who this might be right for
Atrial Fibrillation
Aswan University 60
Not applicableStudy completedNCT05162014
What this trial is testing

To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 494,679
Post-approval studies (Phase 4)Looking for participantsNCT06249945
What this trial is testing

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Who this might be right for
Heart Failure With Preserved Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital 150
Large-scale testing (Phase 3)UnknownNCT05373004
What this trial is testing

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2
Omar Tarek Elfarargi 212
Post-approval studies (Phase 4)Study completedNCT07589075
What this trial is testing

Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation

Who this might be right for
Induction of Ovulation
Beni-Suef University 500
Post-approval studies (Phase 4)Ended earlyNCT05346653
What this trial is testing

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of Chicago 1
Not applicableStudy completedNCT02993614
What this trial is testing

Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

Who this might be right for
Diabetes Mellitus Type 2
AstraZeneca 99,999
Not applicableStudy completedNCT06964607
What this trial is testing

Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

Who this might be right for
Sodium-glucose Cotransporter 2InhibitorsClinical Outcome+2 more
Tanta University 80
Post-approval studies (Phase 4)Looking for participantsNCT07700940
What this trial is testing

The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

Who this might be right for
Lupus Nephritis (LN)
Ahmed Yehia Ismail 66
Not applicableActive Not RecruitingNCT05882071
What this trial is testing

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547,150
Very early researchStudy completedNCT06812429
What this trial is testing

Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation

Who this might be right for
Inflammation
Washington University School of Medicine 6
Next Page